ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Teva Announces FDA Approval of QVAR RediHaler
americanpharmaceuticalreview
August 11, 2017Teva Pharmaceutical announced the U.S. Food and Drug Administration (FDA) has approved QVAR RediHaler inhalation aerosol, a breath-actuated inhaler for the maintenance treatment of asthma as a prophylactic therapy in patients 4 years of age and older.
Pharma Sources Insight July 2025
